Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus

At the discretion of the investigator, pediatric patients could be treated with commercially available everolimus, as per local product information / standard of care. Treatment duration and dose modifications were at the investigator's discretion, as per the local product information.